大腸がん診断薬の世界市場

大腸がん診断薬の世界市場は2030年までに306億米ドルに達する見込み

2024年に225億米ドルと推定される大腸がん診断薬の世界市場は、2024～2030年の分析期間にCAGR 5.3％で成長し、2030年には306億米ドルに達すると予測されます。本レポートで分析したセグメントの1つである腺がんは、CAGR 6.7%を記録し、分析期間終了時には137億米ドルに達すると予測されます。大腸リンパ腫セグメントの成長率は、分析期間中CAGR 3.5%と推定されます。

米国市場は61億米ドルと推定、中国はCAGR 8.6％で成長すると予測

米国の大腸がん診断薬市場は、2024年に61億米ドルと推定されます。世界第2位の経済大国である中国は、2030年までに62億米ドルの市場規模に達すると予測され、分析期間2024-2030年のCAGRは8.6%です。その他の注目すべき地域別市場としては、日本とカナダがあり、分析期間中のCAGRはそれぞれ2.5％と5.3％と予測されています。欧州では、ドイツがCAGR 3.4%で成長すると予測されています。

世界の大腸がん診断薬市場- 主要動向と促進要因のまとめ

技術の進歩は大腸がん検出をどのように強化しているか？

大腸がん（CRC）診断の状況は、早期発見と患者の転帰の改善を目指した技術革新に後押しされ、大きな変革期を迎えています。大腸内視鏡検査や便潜血検査（FOBT）のような従来の方法は、CRCスクリーニングの要でした。しかし、便免疫化学検査（FIT）や便DNA検査のような非侵襲的検査法の出現は、その使いやすさと患者のコンプライアンスにより支持を集めています。これらの方法は侵襲性の低い代替法を提供し、より多くの人が定期的なスクリーニングプログラムに参加することを促します。

さらに、診断手順における人工知能（AI）と機械学習アルゴリズムの統合は、CRC検出の精度と効率を高めています。画像データを分析し、ポリープを特定し、悪性リスクをより正確に評価するために、AIを搭載したツールが開発されています。この技術シフトは、診断プロセスを合理化するだけでなく、効果的な治療と生存率の向上に不可欠ながん病変の早期同定を支援します。

CRC診断の将来においてリキッドバイオプシーが果たす役割とは？

リキッドバイオプシー技術はCRC診断の分野で有望なフロンティアとして浮上しています。患者の血液中の循環腫瘍DNA（ctDNA）を分析することで、リキッドバイオプシーはがんに関連する遺伝子変異を検出する低侵襲な方法を提供します。このアプローチは早期診断を容易にし、治療反応をモニターし、高感度で再発の可能性を検出します。リキッドバイオプシーの採用は、従来の侵襲的な処置を受けることができない、あるいは受けたくない患者にとって特に有益です。

Guardant Health社のShieldやExact Sciences社の今後の製品のような血液ベースの検査の開発は、CRCスクリーニングに革命をもたらすリキッドバイオプシーの可能性を例証しています。これらの検査は、既存のスクリーニング法を補完し、早期発見と個別化治療戦略のための新たなツールを提供することを目的としています。調査が進み、有効性が検証されるにつれて、リキッドバイオプシーは包括的なCRC診断プロトコルの不可欠な要素になる準備が整っています。

市場力学とヘルスケア政策はCRC診断薬の採用にどのような影響を与えているか？

世界のCRC診断薬市場は、罹患率の上昇、高齢化、早期発見の重要性に対する意識の高まりといった要因の影響を受けて成長を遂げています。ヘルスケア政策と償還の枠組みは、診断技術の採用を形成する上で極めて重要な役割を果たしています。例えば、国の検診プログラムや保険適用に特定の検査が含まれることで、その利用が大幅に促進される可能性があります。

北米や欧州のような地域では、定期的なCRC検診を推進する政府の取り組みにより、参加率の向上と早期診断につながっています。一方、新興諸国では、ヘルスケアサービスへのアクセスが限られており、認知度も低いため、普及には課題があります。このような格差に対処するための取り組みとして、公衆衛生キャンペーン、移動検診ユニット、非政府組織とのパートナーシップによる普及とアクセスの拡大などがあります。

大腸がん診断薬市場の成長はいくつかの要因によって牽引...

大腸がん診断薬市場の成長は、技術の進歩、ヘルスケアインフラの開拓、人口動向の変化と密接に結びついたいくつかの要因によって牽引されています。CRCの有病率の増加、特に高齢化により、効果的なスクリーニングと診断ソリューションの必要性が高まっています。FIT、便DNA検査、リキッドバイオプシーなどの非侵襲的検査法の革新は、患者のコンプライアンスを高め、悪性腫瘍の早期発見を可能にしています。

さらに、診断手順におけるAIと機械学習の統合は、精度と効率を向上させ、タイムリーな介入を容易にしています。定期的なスクリーニングを支援し、高度な診断検査に対する償還を提供するヘルスケア政策は、市場の拡大をさらに後押ししています。CRCと早期発見の重要性に関する認識を高める取り組みと、十分なサービスを受けていない地域における検診サービスへのアクセスを改善する取り組みも、市場の成長軌道に寄与しています。これらの要因が相まって、患者の転帰を改善し、この疾患の世界の負担を軽減することに重点を置いた、ダイナミックで進化する情勢が形成されつつあります。

セグメント

がんタイプ（腺がん、大腸リンパ腫、消化管間質腫瘍、カルチノイド腫瘍、その他のがんタイプ）、製品タイプ（器具、消耗品および付属品）、最終用途（病院、診断センター、がん研究センター、外来手術センター、その他の最終用途）

調査対象企業の例（注目の37社）

• Abbott Laboratories
• Amgen Inc.
• Becton, Dickinson and Company
• Bruker Corporation
• Clinical Genomics Technologies Pty Ltd
• Danaher Corporation
• EDP Biotech Corporation
• Eiken Chemical Co., Ltd.
• Epigenomics AG
• Exact Sciences Corporation
• F. Hoffmann-La Roche AG
• Fujirebio
• GE Healthcare
• Geneoscopy Inc.
• Guardant Health, Inc.
• Hologic, Inc.
• Illumina, Inc.
• Medtronic plc
• Novigenix SA
• Quest Diagnostics Incorporated

AIインテグレーション

私たちは、有効な専門家コンテンツとAIツールによって、市場情報と競合情報を変革しています。

Global Industry Analystsは、LLMや業界固有のSLMを照会する一般的な規範に従う代わりに、ビデオ記録、ブログ、検索エンジン調査、膨大な量の企業、製品/サービス、市場データなど、世界中の専門家から収集したコンテンツのリポジトリを構築しました。

関税影響係数

Global Industry Analystsは、本社の国、製造拠点、輸出入（完成品とOEM）に基づく企業の競争力の変化を予測しています。この複雑で多面的な市場力学は、売上原価（COGS）の増加、収益性の低下、サプライチェーンの再構築など、ミクロおよびマクロの市場力学の中でも特に競合他社に影響を与える見込みです。

目次

第1章 調査手法

第2章 エグゼクティブサマリー

• 市場概要
• 主要企業
• 市場動向と促進要因
• 世界市場の見通し

第3章 市場分析

• 米国
• カナダ
• 日本
• 中国
• 欧州
• フランス
• ドイツ
• イタリア
• 英国
• スペイン
• ロシア
• その他欧州
• アジア太平洋
• オーストラリア
• インド
• 韓国
• その他アジア太平洋地域
• ラテンアメリカ
• アルゼンチン
• ブラジル
• メキシコ
• その他ラテンアメリカ
• 中東
• イラン
• イスラエル
• サウジアラビア
• アラブ首長国連邦
• その他中東
• アフリカ

第4章 競合

Global Colorectal Cancer Diagnostics Market to Reach US$30.6 Billion by 2030

The global market for Colorectal Cancer Diagnostics estimated at US$22.5 Billion in the year 2024, is expected to reach US$30.6 Billion by 2030, growing at a CAGR of 5.3% over the analysis period 2024-2030. Adenocarcinoma, one of the segments analyzed in the report, is expected to record a 6.7% CAGR and reach US$13.7 Billion by the end of the analysis period. Growth in the Colorectal Lymphoma segment is estimated at 3.5% CAGR over the analysis period.

The U.S. Market is Estimated at US$6.1 Billion While China is Forecast to Grow at 8.6% CAGR

The Colorectal Cancer Diagnostics market in the U.S. is estimated at US$6.1 Billion in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$6.2 Billion by the year 2030 trailing a CAGR of 8.6% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 2.5% and 5.3% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 3.4% CAGR.

Global Colorectal Cancer Diagnostics Market - Key Trends & Drivers Summarized

How Are Technological Advancements Enhancing Colorectal Cancer Detection?

The landscape of colorectal cancer (CRC) diagnostics is undergoing a significant transformation, propelled by technological innovations aimed at improving early detection and patient outcomes. Traditional methods like colonoscopy and fecal occult blood tests (FOBT) have been the cornerstone of CRC screening. However, the emergence of non-invasive techniques such as fecal immunochemical tests (FIT) and stool DNA tests is gaining traction due to their ease of use and patient compliance. These methods offer a less invasive alternative, encouraging more individuals to participate in regular screening programs.

Moreover, the integration of artificial intelligence (AI) and machine learning algorithms in diagnostic procedures is enhancing the accuracy and efficiency of CRC detection. AI-powered tools are being developed to analyze imaging data, identify polyps, and assess malignancy risks with greater precision. This technological shift not only streamlines the diagnostic process but also aids in the early identification of cancerous lesions, which is crucial for effective treatment and improved survival rates.

What Role Do Liquid Biopsies Play in the Future of CRC Diagnostics?

Liquid biopsy technology is emerging as a promising frontier in the field of CRC diagnostics. By analyzing circulating tumor DNA (ctDNA) in a patient's blood, liquid biopsies offer a minimally invasive method to detect cancer-related genetic mutations. This approach facilitates early diagnosis, monitors treatment responses, and detects potential recurrences with high sensitivity. The adoption of liquid biopsies is particularly beneficial for patients who are unable or unwilling to undergo traditional invasive procedures.

The development of blood-based tests like Guardant Health's Shield and Exact Sciences' upcoming offerings exemplify the potential of liquid biopsies in revolutionizing CRC screening. These tests aim to complement existing screening methods, providing an additional tool for early detection and personalized treatment strategies. As research progresses and validation studies confirm their efficacy, liquid biopsies are poised to become an integral component of comprehensive CRC diagnostic protocols.

How Are Market Dynamics and Healthcare Policies Influencing CRC Diagnostic Adoption?

The global CRC diagnostics market is experiencing growth, influenced by factors such as rising incidence rates, aging populations, and increased awareness of the importance of early detection. Healthcare policies and reimbursement frameworks play a pivotal role in shaping the adoption of diagnostic technologies. For instance, the inclusion of certain tests in national screening programs and insurance coverage can significantly boost their utilization.

In regions like North America and Europe, government initiatives promoting regular CRC screening have led to higher participation rates and early-stage diagnoses. Conversely, in developing countries, limited access to healthcare services and lack of awareness pose challenges to widespread adoption. Efforts to address these disparities include public health campaigns, mobile screening units, and partnerships with non-governmental organizations to expand reach and accessibility.

The Growth in the Colorectal Cancer Diagnostics Market Is Driven by Several Factors…

The growth in the colorectal cancer diagnostics market is driven by several factors closely tied to technological advancements, healthcare infrastructure development, and shifting demographic trends. The increasing prevalence of CRC, particularly among aging populations, underscores the need for effective screening and diagnostic solutions. Innovations in non-invasive testing methods, such as FIT, stool DNA tests, and liquid biopsies, are enhancing patient compliance and enabling earlier detection of malignancies.

Additionally, the integration of AI and machine learning in diagnostic procedures is improving accuracy and efficiency, facilitating timely interventions. Healthcare policies that support regular screening and provide reimbursement for advanced diagnostic tests are further propelling market expansion. Efforts to raise awareness about CRC and the importance of early detection, coupled with initiatives to improve access to screening services in underserved regions, are also contributing to the market's growth trajectory. Collectively, these factors are shaping a dynamic and evolving landscape for colorectal cancer diagnostics, with a focus on improving patient outcomes and reducing the global burden of the disease.

SCOPE OF STUDY:

The report analyzes the Colorectal Cancer Diagnostics market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Cancer Type (Adenocarcinoma, Colorectal Lymphoma, Gastrointestinal Stromal Tumors, Carcinoid Tumors, Other Cancer Types); Product Type (Instruments, Consumables & Accessories); End-Use (Hospitals, Diagnostic Centers, Cancer Research Centers, Ambulatory Surgery Centers, Other End-Uses)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 37 Featured) -

• Abbott Laboratories
• Amgen Inc.
• Becton, Dickinson and Company
• Bruker Corporation
• Clinical Genomics Technologies Pty Ltd
• Danaher Corporation
• EDP Biotech Corporation
• Eiken Chemical Co., Ltd.
• Epigenomics AG
• Exact Sciences Corporation
• F. Hoffmann-La Roche AG
• Fujirebio
• GE Healthcare
• Geneoscopy Inc.
• Guardant Health, Inc.
• Hologic, Inc.
• Illumina, Inc.
• Medtronic plc
• Novigenix SA
• Quest Diagnostics Incorporated

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

• 1. MARKET OVERVIEW
  • Influencer Market Insights
  • World Market Trajectories
  • Tariff Impact on Global Supply Chain Patterns
  • Colorectal Cancer Diagnostics - Global Key Competitors Percentage Market Share in 2025 (E)
  • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
• 2. FOCUS ON SELECT PLAYERS
• 3. MARKET TRENDS & DRIVERS
  • Rising Global Incidence of Colorectal Cancer Propels Demand for Early Diagnostic Screening Technologies
  • Growing Awareness Campaigns and National Screening Programs Expand Market for Routine Colorectal Cancer Testing
  • Increased Emphasis on Early Detection Strengthens Business Case for Non-Invasive Diagnostic Modalities
  • Rapid Adoption of Molecular and Genetic Biomarker Tests Drives Shift Toward Personalized Colorectal Cancer Diagnostics
  • Advancements in Liquid Biopsy Techniques Accelerate Market Penetration of Blood-Based Colorectal Cancer Tests
  • Expansion of Home-Based and Self-Sampling Kits Spurs Consumer Adoption of At-Home Colorectal Screening Solutions
  • Integration of AI and Machine Learning in Diagnostic Imaging Enhances Accuracy of Colonoscopy and CT Colonography
  • Rising Demand for Cost-Effective Screening Options in Low- and Middle-Income Countries Expands Market for FIT and FOBT Kits
  • Shift Toward Multi-Cancer Early Detection (MCED) Panels Puts Spotlight on Colorectal Cancer Biomarker Development
  • Growing Use of Next-Generation Sequencing (NGS) in CRC Risk Assessment Propels Demand for Genomic-Based Diagnostics
  • Increasing Incidence of Early-Onset Colorectal Cancer Generates Urgent Demand for Age-Adjusted Diagnostic Strategies
• 4. GLOBAL MARKET PERSPECTIVE
  • TABLE 1: World Colorectal Cancer Diagnostics Market Analysis of Annual Sales in US$ Million for Years 2015 through 2030
  • TABLE 2: World Recent Past, Current & Future Analysis for Colorectal Cancer Diagnostics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 3: World Historic Review for Colorectal Cancer Diagnostics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 4: World 15-Year Perspective for Colorectal Cancer Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2015, 2025 & 2030
  • TABLE 5: World Recent Past, Current & Future Analysis for Adenocarcinoma by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 6: World Historic Review for Adenocarcinoma by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 7: World 15-Year Perspective for Adenocarcinoma by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 8: World Recent Past, Current & Future Analysis for Colorectal Lymphoma by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 9: World Historic Review for Colorectal Lymphoma by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 10: World 15-Year Perspective for Colorectal Lymphoma by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 11: World Recent Past, Current & Future Analysis for Gastrointestinal Stromal Tumors by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 12: World Historic Review for Gastrointestinal Stromal Tumors by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 13: World 15-Year Perspective for Gastrointestinal Stromal Tumors by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 14: World Recent Past, Current & Future Analysis for Carcinoid Tumors by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 15: World Historic Review for Carcinoid Tumors by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 16: World 15-Year Perspective for Carcinoid Tumors by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 17: World Recent Past, Current & Future Analysis for Other Cancer Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 18: World Historic Review for Other Cancer Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 19: World 15-Year Perspective for Other Cancer Types by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 20: World Recent Past, Current & Future Analysis for Cancer Research Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 21: World Historic Review for Cancer Research Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 22: World 15-Year Perspective for Cancer Research Centers by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 23: World Recent Past, Current & Future Analysis for Ambulatory Surgery Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 24: World Historic Review for Ambulatory Surgery Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 25: World 15-Year Perspective for Ambulatory Surgery Centers by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 26: World Recent Past, Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 27: World Historic Review for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 28: World 15-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 29: World Recent Past, Current & Future Analysis for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 30: World Historic Review for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 31: World 15-Year Perspective for Hospitals by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 32: World Recent Past, Current & Future Analysis for Diagnostic Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 33: World Historic Review for Diagnostic Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 34: World 15-Year Perspective for Diagnostic Centers by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 35: World Recent Past, Current & Future Analysis for Instruments by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 36: World Historic Review for Instruments by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 37: World 15-Year Perspective for Instruments by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 38: World Recent Past, Current & Future Analysis for Consumables & Accessories by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 39: World Historic Review for Consumables & Accessories by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 40: World 15-Year Perspective for Consumables & Accessories by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030

III. MARKET ANALYSIS

• UNITED STATES
  • Colorectal Cancer Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
  • TABLE 41: USA Recent Past, Current & Future Analysis for Colorectal Cancer Diagnostics by Cancer Type - Adenocarcinoma, Colorectal Lymphoma, Gastrointestinal Stromal Tumors, Carcinoid Tumors and Other Cancer Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 42: USA Historic Review for Colorectal Cancer Diagnostics by Cancer Type - Adenocarcinoma, Colorectal Lymphoma, Gastrointestinal Stromal Tumors, Carcinoid Tumors and Other Cancer Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 43: USA 15-Year Perspective for Colorectal Cancer Diagnostics by Cancer Type - Percentage Breakdown of Value Sales for Adenocarcinoma, Colorectal Lymphoma, Gastrointestinal Stromal Tumors, Carcinoid Tumors and Other Cancer Types for the Years 2015, 2025 & 2030
  • TABLE 44: USA Recent Past, Current & Future Analysis for Colorectal Cancer Diagnostics by End-Use - Cancer Research Centers, Ambulatory Surgery Centers, Other End-Uses, Hospitals and Diagnostic Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 45: USA Historic Review for Colorectal Cancer Diagnostics by End-Use - Cancer Research Centers, Ambulatory Surgery Centers, Other End-Uses, Hospitals and Diagnostic Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 46: USA 15-Year Perspective for Colorectal Cancer Diagnostics by End-Use - Percentage Breakdown of Value Sales for Cancer Research Centers, Ambulatory Surgery Centers, Other End-Uses, Hospitals and Diagnostic Centers for the Years 2015, 2025 & 2030
  • TABLE 47: USA Recent Past, Current & Future Analysis for Colorectal Cancer Diagnostics by Product Type - Instruments and Consumables & Accessories - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 48: USA Historic Review for Colorectal Cancer Diagnostics by Product Type - Instruments and Consumables & Accessories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 49: USA 15-Year Perspective for Colorectal Cancer Diagnostics by Product Type - Percentage Breakdown of Value Sales for Instruments and Consumables & Accessories for the Years 2015, 2025 & 2030
• CANADA
  • TABLE 50: Canada Recent Past, Current & Future Analysis for Colorectal Cancer Diagnostics by Cancer Type - Adenocarcinoma, Colorectal Lymphoma, Gastrointestinal Stromal Tumors, Carcinoid Tumors and Other Cancer Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 51: Canada Historic Review for Colorectal Cancer Diagnostics by Cancer Type - Adenocarcinoma, Colorectal Lymphoma, Gastrointestinal Stromal Tumors, Carcinoid Tumors and Other Cancer Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 52: Canada 15-Year Perspective for Colorectal Cancer Diagnostics by Cancer Type - Percentage Breakdown of Value Sales for Adenocarcinoma, Colorectal Lymphoma, Gastrointestinal Stromal Tumors, Carcinoid Tumors and Other Cancer Types for the Years 2015, 2025 & 2030
  • TABLE 53: Canada Recent Past, Current & Future Analysis for Colorectal Cancer Diagnostics by End-Use - Cancer Research Centers, Ambulatory Surgery Centers, Other End-Uses, Hospitals and Diagnostic Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 54: Canada Historic Review for Colorectal Cancer Diagnostics by End-Use - Cancer Research Centers, Ambulatory Surgery Centers, Other End-Uses, Hospitals and Diagnostic Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 55: Canada 15-Year Perspective for Colorectal Cancer Diagnostics by End-Use - Percentage Breakdown of Value Sales for Cancer Research Centers, Ambulatory Surgery Centers, Other End-Uses, Hospitals and Diagnostic Centers for the Years 2015, 2025 & 2030
  • TABLE 56: Canada Recent Past, Current & Future Analysis for Colorectal Cancer Diagnostics by Product Type - Instruments and Consumables & Accessories - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 57: Canada Historic Review for Colorectal Cancer Diagnostics by Product Type - Instruments and Consumables & Accessories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 58: Canada 15-Year Perspective for Colorectal Cancer Diagnostics by Product Type - Percentage Breakdown of Value Sales for Instruments and Consumables & Accessories for the Years 2015, 2025 & 2030
• JAPAN
  • Colorectal Cancer Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
  • TABLE 59: Japan Recent Past, Current & Future Analysis for Colorectal Cancer Diagnostics by Cancer Type - Adenocarcinoma, Colorectal Lymphoma, Gastrointestinal Stromal Tumors, Carcinoid Tumors and Other Cancer Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 60: Japan Historic Review for Colorectal Cancer Diagnostics by Cancer Type - Adenocarcinoma, Colorectal Lymphoma, Gastrointestinal Stromal Tumors, Carcinoid Tumors and Other Cancer Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 61: Japan 15-Year Perspective for Colorectal Cancer Diagnostics by Cancer Type - Percentage Breakdown of Value Sales for Adenocarcinoma, Colorectal Lymphoma, Gastrointestinal Stromal Tumors, Carcinoid Tumors and Other Cancer Types for the Years 2015, 2025 & 2030
  • TABLE 62: Japan Recent Past, Current & Future Analysis for Colorectal Cancer Diagnostics by End-Use - Cancer Research Centers, Ambulatory Surgery Centers, Other End-Uses, Hospitals and Diagnostic Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 63: Japan Historic Review for Colorectal Cancer Diagnostics by End-Use - Cancer Research Centers, Ambulatory Surgery Centers, Other End-Uses, Hospitals and Diagnostic Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 64: Japan 15-Year Perspective for Colorectal Cancer Diagnostics by End-Use - Percentage Breakdown of Value Sales for Cancer Research Centers, Ambulatory Surgery Centers, Other End-Uses, Hospitals and Diagnostic Centers for the Years 2015, 2025 & 2030
  • TABLE 65: Japan Recent Past, Current & Future Analysis for Colorectal Cancer Diagnostics by Product Type - Instruments and Consumables & Accessories - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 66: Japan Historic Review for Colorectal Cancer Diagnostics by Product Type - Instruments and Consumables & Accessories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 67: Japan 15-Year Perspective for Colorectal Cancer Diagnostics by Product Type - Percentage Breakdown of Value Sales for Instruments and Consumables & Accessories for the Years 2015, 2025 & 2030
• CHINA
  • Colorectal Cancer Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
  • TABLE 68: China Recent Past, Current & Future Analysis for Colorectal Cancer Diagnostics by Cancer Type - Adenocarcinoma, Colorectal Lymphoma, Gastrointestinal Stromal Tumors, Carcinoid Tumors and Other Cancer Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 69: China Historic Review for Colorectal Cancer Diagnostics by Cancer Type - Adenocarcinoma, Colorectal Lymphoma, Gastrointestinal Stromal Tumors, Carcinoid Tumors and Other Cancer Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 70: China 15-Year Perspective for Colorectal Cancer Diagnostics by Cancer Type - Percentage Breakdown of Value Sales for Adenocarcinoma, Colorectal Lymphoma, Gastrointestinal Stromal Tumors, Carcinoid Tumors and Other Cancer Types for the Years 2015, 2025 & 2030
  • TABLE 71: China Recent Past, Current & Future Analysis for Colorectal Cancer Diagnostics by End-Use - Cancer Research Centers, Ambulatory Surgery Centers, Other End-Uses, Hospitals and Diagnostic Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 72: China Historic Review for Colorectal Cancer Diagnostics by End-Use - Cancer Research Centers, Ambulatory Surgery Centers, Other End-Uses, Hospitals and Diagnostic Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 73: China 15-Year Perspective for Colorectal Cancer Diagnostics by End-Use - Percentage Breakdown of Value Sales for Cancer Research Centers, Ambulatory Surgery Centers, Other End-Uses, Hospitals and Diagnostic Centers for the Years 2015, 2025 & 2030
  • TABLE 74: China Recent Past, Current & Future Analysis for Colorectal Cancer Diagnostics by Product Type - Instruments and Consumables & Accessories - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 75: China Historic Review for Colorectal Cancer Diagnostics by Product Type - Instruments and Consumables & Accessories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 76: China 15-Year Perspective for Colorectal Cancer Diagnostics by Product Type - Percentage Breakdown of Value Sales for Instruments and Consumables & Accessories for the Years 2015, 2025 & 2030
• EUROPE
  • Colorectal Cancer Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
  • TABLE 77: Europe Recent Past, Current & Future Analysis for Colorectal Cancer Diagnostics by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 78: Europe Historic Review for Colorectal Cancer Diagnostics by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 79: Europe 15-Year Perspective for Colorectal Cancer Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2015, 2025 & 2030
  • TABLE 80: Europe Recent Past, Current & Future Analysis for Colorectal Cancer Diagnostics by Cancer Type - Adenocarcinoma, Colorectal Lymphoma, Gastrointestinal Stromal Tumors, Carcinoid Tumors and Other Cancer Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 81: Europe Historic Review for Colorectal Cancer Diagnostics by Cancer Type - Adenocarcinoma, Colorectal Lymphoma, Gastrointestinal Stromal Tumors, Carcinoid Tumors and Other Cancer Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 82: Europe 15-Year Perspective for Colorectal Cancer Diagnostics by Cancer Type - Percentage Breakdown of Value Sales for Adenocarcinoma, Colorectal Lymphoma, Gastrointestinal Stromal Tumors, Carcinoid Tumors and Other Cancer Types for the Years 2015, 2025 & 2030
  • TABLE 83: Europe Recent Past, Current & Future Analysis for Colorectal Cancer Diagnostics by End-Use - Cancer Research Centers, Ambulatory Surgery Centers, Other End-Uses, Hospitals and Diagnostic Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 84: Europe Historic Review for Colorectal Cancer Diagnostics by End-Use - Cancer Research Centers, Ambulatory Surgery Centers, Other End-Uses, Hospitals and Diagnostic Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 85: Europe 15-Year Perspective for Colorectal Cancer Diagnostics by End-Use - Percentage Breakdown of Value Sales for Cancer Research Centers, Ambulatory Surgery Centers, Other End-Uses, Hospitals and Diagnostic Centers for the Years 2015, 2025 & 2030
  • TABLE 86: Europe Recent Past, Current & Future Analysis for Colorectal Cancer Diagnostics by Product Type - Instruments and Consumables & Accessories - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 87: Europe Historic Review for Colorectal Cancer Diagnostics by Product Type - Instruments and Consumables & Accessories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 88: Europe 15-Year Perspective for Colorectal Cancer Diagnostics by Product Type - Percentage Breakdown of Value Sales for Instruments and Consumables & Accessories for the Years 2015, 2025 & 2030
• FRANCE
  • Colorectal Cancer Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
  • TABLE 89: France Recent Past, Current & Future Analysis for Colorectal Cancer Diagnostics by Cancer Type - Adenocarcinoma, Colorectal Lymphoma, Gastrointestinal Stromal Tumors, Carcinoid Tumors and Other Cancer Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 90: France Historic Review for Colorectal Cancer Diagnostics by Cancer Type - Adenocarcinoma, Colorectal Lymphoma, Gastrointestinal Stromal Tumors, Carcinoid Tumors and Other Cancer Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 91: France 15-Year Perspective for Colorectal Cancer Diagnostics by Cancer Type - Percentage Breakdown of Value Sales for Adenocarcinoma, Colorectal Lymphoma, Gastrointestinal Stromal Tumors, Carcinoid Tumors and Other Cancer Types for the Years 2015, 2025 & 2030
  • TABLE 92: France Recent Past, Current & Future Analysis for Colorectal Cancer Diagnostics by End-Use - Cancer Research Centers, Ambulatory Surgery Centers, Other End-Uses, Hospitals and Diagnostic Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 93: France Historic Review for Colorectal Cancer Diagnostics by End-Use - Cancer Research Centers, Ambulatory Surgery Centers, Other End-Uses, Hospitals and Diagnostic Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 94: France 15-Year Perspective for Colorectal Cancer Diagnostics by End-Use - Percentage Breakdown of Value Sales for Cancer Research Centers, Ambulatory Surgery Centers, Other End-Uses, Hospitals and Diagnostic Centers for the Years 2015, 2025 & 2030
  • TABLE 95: France Recent Past, Current & Future Analysis for Colorectal Cancer Diagnostics by Product Type - Instruments and Consumables & Accessories - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 96: France Historic Review for Colorectal Cancer Diagnostics by Product Type - Instruments and Consumables & Accessories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 97: France 15-Year Perspective for Colorectal Cancer Diagnostics by Product Type - Percentage Breakdown of Value Sales for Instruments and Consumables & Accessories for the Years 2015, 2025 & 2030
• GERMANY
  • Colorectal Cancer Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
  • TABLE 98: Germany Recent Past, Current & Future Analysis for Colorectal Cancer Diagnostics by Cancer Type - Adenocarcinoma, Colorectal Lymphoma, Gastrointestinal Stromal Tumors, Carcinoid Tumors and Other Cancer Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 99: Germany Historic Review for Colorectal Cancer Diagnostics by Cancer Type - Adenocarcinoma, Colorectal Lymphoma, Gastrointestinal Stromal Tumors, Carcinoid Tumors and Other Cancer Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 100: Germany 15-Year Perspective for Colorectal Cancer Diagnostics by Cancer Type - Percentage Breakdown of Value Sales for Adenocarcinoma, Colorectal Lymphoma, Gastrointestinal Stromal Tumors, Carcinoid Tumors and Other Cancer Types for the Years 2015, 2025 & 2030
  • TABLE 101: Germany Recent Past, Current & Future Analysis for Colorectal Cancer Diagnostics by End-Use - Cancer Research Centers, Ambulatory Surgery Centers, Other End-Uses, Hospitals and Diagnostic Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 102: Germany Historic Review for Colorectal Cancer Diagnostics by End-Use - Cancer Research Centers, Ambulatory Surgery Centers, Other End-Uses, Hospitals and Diagnostic Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 103: Germany 15-Year Perspective for Colorectal Cancer Diagnostics by End-Use - Percentage Breakdown of Value Sales for Cancer Research Centers, Ambulatory Surgery Centers, Other End-Uses, Hospitals and Diagnostic Centers for the Years 2015, 2025 & 2030
  • TABLE 104: Germany Recent Past, Current & Future Analysis for Colorectal Cancer Diagnostics by Product Type - Instruments and Consumables & Accessories - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 105: Germany Historic Review for Colorectal Cancer Diagnostics by Product Type - Instruments and Consumables & Accessories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 106: Germany 15-Year Perspective for Colorectal Cancer Diagnostics by Product Type - Percentage Breakdown of Value Sales for Instruments and Consumables & Accessories for the Years 2015, 2025 & 2030
• ITALY
  • TABLE 107: Italy Recent Past, Current & Future Analysis for Colorectal Cancer Diagnostics by Cancer Type - Adenocarcinoma, Colorectal Lymphoma, Gastrointestinal Stromal Tumors, Carcinoid Tumors and Other Cancer Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 108: Italy Historic Review for Colorectal Cancer Diagnostics by Cancer Type - Adenocarcinoma, Colorectal Lymphoma, Gastrointestinal Stromal Tumors, Carcinoid Tumors and Other Cancer Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 109: Italy 15-Year Perspective for Colorectal Cancer Diagnostics by Cancer Type - Percentage Breakdown of Value Sales for Adenocarcinoma, Colorectal Lymphoma, Gastrointestinal Stromal Tumors, Carcinoid Tumors and Other Cancer Types for the Years 2015, 2025 & 2030
  • TABLE 110: Italy Recent Past, Current & Future Analysis for Colorectal Cancer Diagnostics by End-Use - Cancer Research Centers, Ambulatory Surgery Centers, Other End-Uses, Hospitals and Diagnostic Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 111: Italy Historic Review for Colorectal Cancer Diagnostics by End-Use - Cancer Research Centers, Ambulatory Surgery Centers, Other End-Uses, Hospitals and Diagnostic Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 112: Italy 15-Year Perspective for Colorectal Cancer Diagnostics by End-Use - Percentage Breakdown of Value Sales for Cancer Research Centers, Ambulatory Surgery Centers, Other End-Uses, Hospitals and Diagnostic Centers for the Years 2015, 2025 & 2030
  • TABLE 113: Italy Recent Past, Current & Future Analysis for Colorectal Cancer Diagnostics by Product Type - Instruments and Consumables & Accessories - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 114: Italy Historic Review for Colorectal Cancer Diagnostics by Product Type - Instruments and Consumables & Accessories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 115: Italy 15-Year Perspective for Colorectal Cancer Diagnostics by Product Type - Percentage Breakdown of Value Sales for Instruments and Consumables & Accessories for the Years 2015, 2025 & 2030
• UNITED KINGDOM
  • Colorectal Cancer Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
  • TABLE 116: UK Recent Past, Current & Future Analysis for Colorectal Cancer Diagnostics by Cancer Type - Adenocarcinoma, Colorectal Lymphoma, Gastrointestinal Stromal Tumors, Carcinoid Tumors and Other Cancer Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 117: UK Historic Review for Colorectal Cancer Diagnostics by Cancer Type - Adenocarcinoma, Colorectal Lymphoma, Gastrointestinal Stromal Tumors, Carcinoid Tumors and Other Cancer Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 118: UK 15-Year Perspective for Colorectal Cancer Diagnostics by Cancer Type - Percentage Breakdown of Value Sales for Adenocarcinoma, Colorectal Lymphoma, Gastrointestinal Stromal Tumors, Carcinoid Tumors and Other Cancer Types for the Years 2015, 2025 & 2030
  • TABLE 119: UK Recent Past, Current & Future Analysis for Colorectal Cancer Diagnostics by End-Use - Cancer Research Centers, Ambulatory Surgery Centers, Other End-Uses, Hospitals and Diagnostic Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 120: UK Historic Review for Colorectal Cancer Diagnostics by End-Use - Cancer Research Centers, Ambulatory Surgery Centers, Other End-Uses, Hospitals and Diagnostic Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 121: UK 15-Year Perspective for Colorectal Cancer Diagnostics by End-Use - Percentage Breakdown of Value Sales for Cancer Research Centers, Ambulatory Surgery Centers, Other End-Uses, Hospitals and Diagnostic Centers for the Years 2015, 2025 & 2030
  • TABLE 122: UK Recent Past, Current & Future Analysis for Colorectal Cancer Diagnostics by Product Type - Instruments and Consumables & Accessories - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 123: UK Historic Review for Colorectal Cancer Diagnostics by Product Type - Instruments and Consumables & Accessories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 124: UK 15-Year Perspective for Colorectal Cancer Diagnostics by Product Type - Percentage Breakdown of Value Sales for Instruments and Consumables & Accessories for the Years 2015, 2025 & 2030
• SPAIN
  • TABLE 125: Spain Recent Past, Current & Future Analysis for Colorectal Cancer Diagnostics by Cancer Type - Adenocarcinoma, Colorectal Lymphoma, Gastrointestinal Stromal Tumors, Carcinoid Tumors and Other Cancer Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 126: Spain Historic Review for Colorectal Cancer Diagnostics by Cancer Type - Adenocarcinoma, Colorectal Lymphoma, Gastrointestinal Stromal Tumors, Carcinoid Tumors and Other Cancer Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 127: Spain 15-Year Perspective for Colorectal Cancer Diagnostics by Cancer Type - Percentage Breakdown of Value Sales for Adenocarcinoma, Colorectal Lymphoma, Gastrointestinal Stromal Tumors, Carcinoid Tumors and Other Cancer Types for the Years 2015, 2025 & 2030
  • TABLE 128: Spain Recent Past, Current & Future Analysis for Colorectal Cancer Diagnostics by End-Use - Cancer Research Centers, Ambulatory Surgery Centers, Other End-Uses, Hospitals and Diagnostic Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 129: Spain Historic Review for Colorectal Cancer Diagnostics by End-Use - Cancer Research Centers, Ambulatory Surgery Centers, Other End-Uses, Hospitals and Diagnostic Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 130: Spain 15-Year Perspective for Colorectal Cancer Diagnostics by End-Use - Percentage Breakdown of Value Sales for Cancer Research Centers, Ambulatory Surgery Centers, Other End-Uses, Hospitals and Diagnostic Centers for the Years 2015, 2025 & 2030
  • TABLE 131: Spain Recent Past, Current & Future Analysis for Colorectal Cancer Diagnostics by Product Type - Instruments and Consumables & Accessories - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 132: Spain Historic Review for Colorectal Cancer Diagnostics by Product Type - Instruments and Consumables & Accessories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 133: Spain 15-Year Perspective for Colorectal Cancer Diagnostics by Product Type - Percentage Breakdown of Value Sales for Instruments and Consumables & Accessories for the Years 2015, 2025 & 2030
• RUSSIA
  • TABLE 134: Russia Recent Past, Current & Future Analysis for Colorectal Cancer Diagnostics by Cancer Type - Adenocarcinoma, Colorectal Lymphoma, Gastrointestinal Stromal Tumors, Carcinoid Tumors and Other Cancer Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 135: Russia Historic Review for Colorectal Cancer Diagnostics by Cancer Type - Adenocarcinoma, Colorectal Lymphoma, Gastrointestinal Stromal Tumors, Carcinoid Tumors and Other Cancer Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 136: Russia 15-Year Perspective for Colorectal Cancer Diagnostics by Cancer Type - Percentage Breakdown of Value Sales for Adenocarcinoma, Colorectal Lymphoma, Gastrointestinal Stromal Tumors, Carcinoid Tumors and Other Cancer Types for the Years 2015, 2025 & 2030
  • TABLE 137: Russia Recent Past, Current & Future Analysis for Colorectal Cancer Diagnostics by End-Use - Cancer Research Centers, Ambulatory Surgery Centers, Other End-Uses, Hospitals and Diagnostic Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 138: Russia Historic Review for Colorectal Cancer Diagnostics by End-Use - Cancer Research Centers, Ambulatory Surgery Centers, Other End-Uses, Hospitals and Diagnostic Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 139: Russia 15-Year Perspective for Colorectal Cancer Diagnostics by End-Use - Percentage Breakdown of Value Sales for Cancer Research Centers, Ambulatory Surgery Centers, Other End-Uses, Hospitals and Diagnostic Centers for the Years 2015, 2025 & 2030
  • TABLE 140: Russia Recent Past, Current & Future Analysis for Colorectal Cancer Diagnostics by Product Type - Instruments and Consumables & Accessories - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 141: Russia Historic Review for Colorectal Cancer Diagnostics by Product Type - Instruments and Consumables & Accessories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 142: Russia 15-Year Perspective for Colorectal Cancer Diagnostics by Product Type - Percentage Breakdown of Value Sales for Instruments and Consumables & Accessories for the Years 2015, 2025 & 2030
• REST OF EUROPE
  • TABLE 143: Rest of Europe Recent Past, Current & Future Analysis for Colorectal Cancer Diagnostics by Cancer Type - Adenocarcinoma, Colorectal Lymphoma, Gastrointestinal Stromal Tumors, Carcinoid Tumors and Other Cancer Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 144: Rest of Europe Historic Review for Colorectal Cancer Diagnostics by Cancer Type - Adenocarcinoma, Colorectal Lymphoma, Gastrointestinal Stromal Tumors, Carcinoid Tumors and Other Cancer Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 145: Rest of Europe 15-Year Perspective for Colorectal Cancer Diagnostics by Cancer Type - Percentage Breakdown of Value Sales for Adenocarcinoma, Colorectal Lymphoma, Gastrointestinal Stromal Tumors, Carcinoid Tumors and Other Cancer Types for the Years 2015, 2025 & 2030
  • TABLE 146: Rest of Europe Recent Past, Current & Future Analysis for Colorectal Cancer Diagnostics by End-Use - Cancer Research Centers, Ambulatory Surgery Centers, Other End-Uses, Hospitals and Diagnostic Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 147: Rest of Europe Historic Review for Colorectal Cancer Diagnostics by End-Use - Cancer Research Centers, Ambulatory Surgery Centers, Other End-Uses, Hospitals and Diagnostic Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 148: Rest of Europe 15-Year Perspective for Colorectal Cancer Diagnostics by End-Use - Percentage Breakdown of Value Sales for Cancer Research Centers, Ambulatory Surgery Centers, Other End-Uses, Hospitals and Diagnostic Centers for the Years 2015, 2025 & 2030
  • TABLE 149: Rest of Europe Recent Past, Current & Future Analysis for Colorectal Cancer Diagnostics by Product Type - Instruments and Consumables & Accessories - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 150: Rest of Europe Historic Review for Colorectal Cancer Diagnostics by Product Type - Instruments and Consumables & Accessories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 151: Rest of Europe 15-Year Perspective for Colorectal Cancer Diagnostics by Product Type - Percentage Breakdown of Value Sales for Instruments and Consumables & Accessories for the Years 2015, 2025 & 2030
• ASIA-PACIFIC
  • Colorectal Cancer Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
  • TABLE 152: Asia-Pacific Recent Past, Current & Future Analysis for Colorectal Cancer Diagnostics by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 153: Asia-Pacific Historic Review for Colorectal Cancer Diagnostics by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 154: Asia-Pacific 15-Year Perspective for Colorectal Cancer Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2015, 2025 & 2030
  • TABLE 155: Asia-Pacific Recent Past, Current & Future Analysis for Colorectal Cancer Diagnostics by Cancer Type - Adenocarcinoma, Colorectal Lymphoma, Gastrointestinal Stromal Tumors, Carcinoid Tumors and Other Cancer Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 156: Asia-Pacific Historic Review for Colorectal Cancer Diagnostics by Cancer Type - Adenocarcinoma, Colorectal Lymphoma, Gastrointestinal Stromal Tumors, Carcinoid Tumors and Other Cancer Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 157: Asia-Pacific 15-Year Perspective for Colorectal Cancer Diagnostics by Cancer Type - Percentage Breakdown of Value Sales for Adenocarcinoma, Colorectal Lymphoma, Gastrointestinal Stromal Tumors, Carcinoid Tumors and Other Cancer Types for the Years 2015, 2025 & 2030
  • TABLE 158: Asia-Pacific Recent Past, Current & Future Analysis for Colorectal Cancer Diagnostics by End-Use - Cancer Research Centers, Ambulatory Surgery Centers, Other End-Uses, Hospitals and Diagnostic Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 159: Asia-Pacific Historic Review for Colorectal Cancer Diagnostics by End-Use - Cancer Research Centers, Ambulatory Surgery Centers, Other End-Uses, Hospitals and Diagnostic Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 160: Asia-Pacific 15-Year Perspective for Colorectal Cancer Diagnostics by End-Use - Percentage Breakdown of Value Sales for Cancer Research Centers, Ambulatory Surgery Centers, Other End-Uses, Hospitals and Diagnostic Centers for the Years 2015, 2025 & 2030
  • TABLE 161: Asia-Pacific Recent Past, Current & Future Analysis for Colorectal Cancer Diagnostics by Product Type - Instruments and Consumables & Accessories - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 162: Asia-Pacific Historic Review for Colorectal Cancer Diagnostics by Product Type - Instruments and Consumables & Accessories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 163: Asia-Pacific 15-Year Perspective for Colorectal Cancer Diagnostics by Product Type - Percentage Breakdown of Value Sales for Instruments and Consumables & Accessories for the Years 2015, 2025 & 2030
• AUSTRALIA
  • Colorectal Cancer Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
  • TABLE 164: Australia Recent Past, Current & Future Analysis for Colorectal Cancer Diagnostics by Cancer Type - Adenocarcinoma, Colorectal Lymphoma, Gastrointestinal Stromal Tumors, Carcinoid Tumors and Other Cancer Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 165: Australia Historic Review for Colorectal Cancer Diagnostics by Cancer Type - Adenocarcinoma, Colorectal Lymphoma, Gastrointestinal Stromal Tumors, Carcinoid Tumors and Other Cancer Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 166: Australia 15-Year Perspective for Colorectal Cancer Diagnostics by Cancer Type - Percentage Breakdown of Value Sales for Adenocarcinoma, Colorectal Lymphoma, Gastrointestinal Stromal Tumors, Carcinoid Tumors and Other Cancer Types for the Years 2015, 2025 & 2030
  • TABLE 167: Australia Recent Past, Current & Future Analysis for Colorectal Cancer Diagnostics by End-Use - Cancer Research Centers, Ambulatory Surgery Centers, Other End-Uses, Hospitals and Diagnostic Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 168: Australia Historic Review for Colorectal Cancer Diagnostics by End-Use - Cancer Research Centers, Ambulatory Surgery Centers, Other End-Uses, Hospitals and Diagnostic Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 169: Australia 15-Year Perspective for Colorectal Cancer Diagnostics by End-Use - Percentage Breakdown of Value Sales for Cancer Research Centers, Ambulatory Surgery Centers, Other End-Uses, Hospitals and Diagnostic Centers for the Years 2015, 2025 & 2030
  • TABLE 170: Australia Recent Past, Current & Future Analysis for Colorectal Cancer Diagnostics by Product Type - Instruments and Consumables & Accessories - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 171: Australia Historic Review for Colorectal Cancer Diagnostics by Product Type - Instruments and Consumables & Accessories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 172: Australia 15-Year Perspective for Colorectal Cancer Diagnostics by Product Type - Percentage Breakdown of Value Sales for Instruments and Consumables & Accessories for the Years 2015, 2025 & 2030
• INDIA
  • Colorectal Cancer Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
  • TABLE 173: India Recent Past, Current & Future Analysis for Colorectal Cancer Diagnostics by Cancer Type - Adenocarcinoma, Colorectal Lymphoma, Gastrointestinal Stromal Tumors, Carcinoid Tumors and Other Cancer Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 174: India Historic Review for Colorectal Cancer Diagnostics by Cancer Type - Adenocarcinoma, Colorectal Lymphoma, Gastrointestinal Stromal Tumors, Carcinoid Tumors and Other Cancer Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 175: India 15-Year Perspective for Colorectal Cancer Diagnostics by Cancer Type - Percentage Breakdown of Value Sales for Adenocarcinoma, Colorectal Lymphoma, Gastrointestinal Stromal Tumors, Carcinoid Tumors and Other Cancer Types for the Years 2015, 2025 & 2030
  • TABLE 176: India Recent Past, Current & Future Analysis for Colorectal Cancer Diagnostics by End-Use - Cancer Research Centers, Ambulatory Surgery Centers, Other End-Uses, Hospitals and Diagnostic Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 177: India Historic Review for Colorectal Cancer Diagnostics by End-Use - Cancer Research Centers, Ambulatory Surgery Centers, Other End-Uses, Hospitals and Diagnostic Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 178: India 15-Year Perspective for Colorectal Cancer Diagnostics by End-Use - Percentage Breakdown of Value Sales for Cancer Research Centers, Ambulatory Surgery Centers, Other End-Uses, Hospitals and Diagnostic Centers for the Years 2015, 2025 & 2030
  • TABLE 179: India Recent Past, Current & Future Analysis for Colorectal Cancer Diagnostics by Product Type - Instruments and Consumables & Accessories - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 180: India Historic Review for Colorectal Cancer Diagnostics by Product Type - Instruments and Consumables & Accessories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 181: India 15-Year Perspective for Colorectal Cancer Diagnostics by Product Type - Percentage Breakdown of Value Sales for Instruments and Consumables & Accessories for the Years 2015, 2025 & 2030
• SOUTH KOREA
  • TABLE 182: South Korea Recent Past, Current & Future Analysis for Colorectal Cancer Diagnostics by Cancer Type - Adenocarcinoma, Colorectal Lymphoma, Gastrointestinal Stromal Tumors, Carcinoid Tumors and Other Cancer Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 183: South Korea Historic Review for Colorectal Cancer Diagnostics by Cancer Type - Adenocarcinoma, Colorectal Lymphoma, Gastrointestinal Stromal Tumors, Carcinoid Tumors and Other Cancer Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 184: South Korea 15-Year Perspective for Colorectal Cancer Diagnostics by Cancer Type - Percentage Breakdown of Value Sales for Adenocarcinoma, Colorectal Lymphoma, Gastrointestinal Stromal Tumors, Carcinoid Tumors and Other Cancer Types for the Years 2015, 2025 & 2030
  • TABLE 185: South Korea Recent Past, Current & Future Analysis for Colorectal Cancer Diagnostics by End-Use - Cancer Research Centers, Ambulatory Surgery Centers, Other End-Uses, Hospitals and Diagnostic Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 186: South Korea Historic Review for Colorectal Cancer Diagnostics by End-Use - Cancer Research Centers, Ambulatory Surgery Centers, Other End-Uses, Hospitals and Diagnostic Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 187: South Korea 15-Year Perspective for Colorectal Cancer Diagnostics by End-Use - Percentage Breakdown of Value Sales for Cancer Research Centers, Ambulatory Surgery Centers, Other End-Uses, Hospitals and Diagnostic Centers for the Years 2015, 2025 & 2030
  • TABLE 188: South Korea Recent Past, Current & Future Analysis for Colorectal Cancer Diagnostics by Product Type - Instruments and Consumables & Accessories - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 189: South Korea Historic Review for Colorectal Cancer Diagnostics by Product Type - Instruments and Consumables & Accessories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 190: South Korea 15-Year Perspective for Colorectal Cancer Diagnostics by Product Type - Percentage Breakdown of Value Sales for Instruments and Consumables & Accessories for the Years 2015, 2025 & 2030
• REST OF ASIA-PACIFIC
  • TABLE 191: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Colorectal Cancer Diagnostics by Cancer Type - Adenocarcinoma, Colorectal Lymphoma, Gastrointestinal Stromal Tumors, Carcinoid Tumors and Other Cancer Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 192: Rest of Asia-Pacific Historic Review for Colorectal Cancer Diagnostics by Cancer Type - Adenocarcinoma, Colorectal Lymphoma, Gastrointestinal Stromal Tumors, Carcinoid Tumors and Other Cancer Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 193: Rest of Asia-Pacific 15-Year Perspective for Colorectal Cancer Diagnostics by Cancer Type - Percentage Breakdown of Value Sales for Adenocarcinoma, Colorectal Lymphoma, Gastrointestinal Stromal Tumors, Carcinoid Tumors and Other Cancer Types for the Years 2015, 2025 & 2030
  • TABLE 194: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Colorectal Cancer Diagnostics by End-Use - Cancer Research Centers, Ambulatory Surgery Centers, Other End-Uses, Hospitals and Diagnostic Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 195: Rest of Asia-Pacific Historic Review for Colorectal Cancer Diagnostics by End-Use - Cancer Research Centers, Ambulatory Surgery Centers, Other End-Uses, Hospitals and Diagnostic Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 196: Rest of Asia-Pacific 15-Year Perspective for Colorectal Cancer Diagnostics by End-Use - Percentage Breakdown of Value Sales for Cancer Research Centers, Ambulatory Surgery Centers, Other End-Uses, Hospitals and Diagnostic Centers for the Years 2015, 2025 & 2030
  • TABLE 197: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Colorectal Cancer Diagnostics by Product Type - Instruments and Consumables & Accessories - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 198: Rest of Asia-Pacific Historic Review for Colorectal Cancer Diagnostics by Product Type - Instruments and Consumables & Accessories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 199: Rest of Asia-Pacific 15-Year Perspective for Colorectal Cancer Diagnostics by Product Type - Percentage Breakdown of Value Sales for Instruments and Consumables & Accessories for the Years 2015, 2025 & 2030
• LATIN AMERICA
  • Colorectal Cancer Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
  • TABLE 200: Latin America Recent Past, Current & Future Analysis for Colorectal Cancer Diagnostics by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 201: Latin America Historic Review for Colorectal Cancer Diagnostics by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 202: Latin America 15-Year Perspective for Colorectal Cancer Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2015, 2025 & 2030
  • TABLE 203: Latin America Recent Past, Current & Future Analysis for Colorectal Cancer Diagnostics by Cancer Type - Adenocarcinoma, Colorectal Lymphoma, Gastrointestinal Stromal Tumors, Carcinoid Tumors and Other Cancer Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 204: Latin America Historic Review for Colorectal Cancer Diagnostics by Cancer Type - Adenocarcinoma, Colorectal Lymphoma, Gastrointestinal Stromal Tumors, Carcinoid Tumors and Other Cancer Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 205: Latin America 15-Year Perspective for Colorectal Cancer Diagnostics by Cancer Type - Percentage Breakdown of Value Sales for Adenocarcinoma, Colorectal Lymphoma, Gastrointestinal Stromal Tumors, Carcinoid Tumors and Other Cancer Types for the Years 2015, 2025 & 2030
  • TABLE 206: Latin America Recent Past, Current & Future Analysis for Colorectal Cancer Diagnostics by End-Use - Cancer Research Centers, Ambulatory Surgery Centers, Other End-Uses, Hospitals and Diagnostic Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 207: Latin America Historic Review for Colorectal Cancer Diagnostics by End-Use - Cancer Research Centers, Ambulatory Surgery Centers, Other End-Uses, Hospitals and Diagnostic Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 208: Latin America 15-Year Perspective for Colorectal Cancer Diagnostics by End-Use - Percentage Breakdown of Value Sales for Cancer Research Centers, Ambulatory Surgery Centers, Other End-Uses, Hospitals and Diagnostic Centers for the Years 2015, 2025 & 2030
  • TABLE 209: Latin America Recent Past, Current & Future Analysis for Colorectal Cancer Diagnostics by Product Type - Instruments and Consumables & Accessories - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 210: Latin America Historic Review for Colorectal Cancer Diagnostics by Product Type - Instruments and Consumables & Accessories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 211: Latin America 15-Year Perspective for Colorectal Cancer Diagnostics by Product Type - Percentage Breakdown of Value Sales for Instruments and Consumables & Accessories for the Years 2015, 2025 & 2030
• ARGENTINA
  • TABLE 212: Argentina Recent Past, Current & Future Analysis for Colorectal Cancer Diagnostics by Cancer Type - Adenocarcinoma, Colorectal Lymphoma, Gastrointestinal Stromal Tumors, Carcinoid Tumors and Other Cancer Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 213: Argentina Historic Review for Colorectal Cancer Diagnostics by Cancer Type - Adenocarcinoma, Colorectal Lymphoma, Gastrointestinal Stromal Tumors, Carcinoid Tumors and Other Cancer Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 214: Argentina 15-Year Perspective for Colorectal Cancer Diagnostics by Cancer Type - Percentage Breakdown of Value Sales for Adenocarcinoma, Colorectal Lymphoma, Gastrointestinal Stromal Tumors, Carcinoid Tumors and Other Cancer Types for the Years 2015, 2025 & 2030
  • TABLE 215: Argentina Recent Past, Current & Future Analysis for Colorectal Cancer Diagnostics by End-Use - Cancer Research Centers, Ambulatory Surgery Centers, Other End-Uses, Hospitals and Diagnostic Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 216: Argentina Historic Review for Colorectal Cancer Diagnostics by End-Use - Cancer Research Centers, Ambulatory Surgery Centers, Other End-Uses, Hospitals and Diagnostic Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 217: Argentina 15-Year Perspective for Colorectal Cancer Diagnostics by End-Use - Percentage Breakdown of Value Sales for Cancer Research Centers, Ambulatory Surgery Centers, Other End-Uses, Hospitals and Diagnostic Centers for the Years 2015, 2025 & 2030
  • TABLE 218: Argentina Recent Past, Current & Future Analysis for Colorectal Cancer Diagnostics by Product Type - Instruments and Consumables & Accessories - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 219: Argentina Historic Review for Colorectal Cancer Diagnostics by Product Type - Instruments and Consumables & Accessories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 220: Argentina 15-Year Perspective for Colorectal Cancer Diagnostics by Product Type - Percentage Breakdown of Value Sales for Instruments and Consumables & Accessories for the Years 2015, 2025 & 2030
• BRAZIL
  • TABLE 221: Brazil Recent Past, Current & Future Analysis for Colorectal Cancer Diagnostics by Cancer Type - Adenocarcinoma, Colorectal Lymphoma, Gastrointestinal Stromal Tumors, Carcinoid Tumors and Other Cancer Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 222: Brazil Historic Review for Colorectal Cancer Diagnostics by Cancer Type - Adenocarcinoma, Colorectal Lymphoma, Gastrointestinal Stromal Tumors, Carcinoid Tumors and Other Cancer Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 223: Brazil 15-Year Perspective for Colorectal Cancer Diagnostics by Cancer Type - Percentage Breakdown of Value Sales for Adenocarcinoma, Colorectal Lymphoma, Gastrointestinal Stromal Tumors, Carcinoid Tumors and Other Cancer Types for the Years 2015, 2025 & 2030
  • TABLE 224: Brazil Recent Past, Current & Future Analysis for Colorectal Cancer Diagnostics by End-Use - Cancer Research Centers, Ambulatory Surgery Centers, Other End-Uses, Hospitals and Diagnostic Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 225: Brazil Historic Review for Colorectal Cancer Diagnostics by End-Use - Cancer Research Centers, Ambulatory Surgery Centers, Other End-Uses, Hospitals and Diagnostic Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 226: Brazil 15-Year Perspective for Colorectal Cancer Diagnostics by End-Use - Percentage Breakdown of Value Sales for Cancer Research Centers, Ambulatory Surgery Centers, Other End-Uses, Hospitals and Diagnostic Centers for the Years 2015, 2025 & 2030
  • TABLE 227: Brazil Recent Past, Current & Future Analysis for Colorectal Cancer Diagnostics by Product Type - Instruments and Consumables & Accessories - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 228: Brazil Historic Review for Colorectal Cancer Diagnostics by Product Type - Instruments and Consumables & Accessories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 229: Brazil 15-Year Perspective for Colorectal Cancer Diagnostics by Product Type - Percentage Breakdown of Value Sales for Instruments and Consumables & Accessories for the Years 2015, 2025 & 2030
• MEXICO
  • TABLE 230: Mexico Recent Past, Current & Future Analysis for Colorectal Cancer Diagnostics by Cancer Type - Adenocarcinoma, Colorectal Lymphoma, Gastrointestinal Stromal Tumors, Carcinoid Tumors and Other Cancer Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 231: Mexico Historic Review for Colorectal Cancer Diagnostics by Cancer Type - Adenocarcinoma, Colorectal Lymphoma, Gastrointestinal Stromal Tumors, Carcinoid Tumors and Other Cancer Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 232: Mexico 15-Year Perspective for Colorectal Cancer Diagnostics by Cancer Type - Percentage Breakdown of Value Sales for Adenocarcinoma, Colorectal Lymphoma, Gastrointestinal Stromal Tumors, Carcinoid Tumors and Other Cancer Types for the Years 2015, 2025 & 2030
  • TABLE 233: Mexico Recent Past, Current & Future Analysis for Colorectal Cancer Diagnostics by End-Use - Cancer Research Centers, Ambulatory Surgery Centers, Other End-Uses, Hospitals and Diagnostic Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 234: Mexico Historic Review for Colorectal Cancer Diagnostics by End-Use - Cancer Research Centers, Ambulatory Surgery Centers, Other End-Uses, Hospitals and Diagnostic Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 235: Mexico 15-Year Perspective for Colorectal Cancer Diagnostics by End-Use - Percentage Breakdown of Value Sales for Cancer Research Centers, Ambulatory Surgery Centers, Other End-Uses, Hospitals and Diagnostic Centers for the Years 2015, 2025 & 2030
  • TABLE 236: Mexico Recent Past, Current & Future Analysis for Colorectal Cancer Diagnostics by Product Type - Instruments and Consumables & Accessories - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 237: Mexico Historic Review for Colorectal Cancer Diagnostics by Product Type - Instruments and Consumables & Accessories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 238: Mexico 15-Year Perspective for Colorectal Cancer Diagnostics by Product Type - Percentage Breakdown of Value Sales for Instruments and Consumables & Accessories for the Years 2015, 2025 & 2030
• REST OF LATIN AMERICA
  • TABLE 239: Rest of Latin America Recent Past, Current & Future Analysis for Colorectal Cancer Diagnostics by Cancer Type - Adenocarcinoma, Colorectal Lymphoma, Gastrointestinal Stromal Tumors, Carcinoid Tumors and Other Cancer Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 240: Rest of Latin America Historic Review for Colorectal Cancer Diagnostics by Cancer Type - Adenocarcinoma, Colorectal Lymphoma, Gastrointestinal Stromal Tumors, Carcinoid Tumors and Other Cancer Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 241: Rest of Latin America 15-Year Perspective for Colorectal Cancer Diagnostics by Cancer Type - Percentage Breakdown of Value Sales for Adenocarcinoma, Colorectal Lymphoma, Gastrointestinal Stromal Tumors, Carcinoid Tumors and Other Cancer Types for the Years 2015, 2025 & 2030
  • TABLE 242: Rest of Latin America Recent Past, Current & Future Analysis for Colorectal Cancer Diagnostics by End-Use - Cancer Research Centers, Ambulatory Surgery Centers, Other End-Uses, Hospitals and Diagnostic Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 243: Rest of Latin America Historic Review for Colorectal Cancer Diagnostics by End-Use - Cancer Research Centers, Ambulatory Surgery Centers, Other End-Uses, Hospitals and Diagnostic Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 244: Rest of Latin America 15-Year Perspective for Colorectal Cancer Diagnostics by End-Use - Percentage Breakdown of Value Sales for Cancer Research Centers, Ambulatory Surgery Centers, Other End-Uses, Hospitals and Diagnostic Centers for the Years 2015, 2025 & 2030
  • TABLE 245: Rest of Latin America Recent Past, Current & Future Analysis for Colorectal Cancer Diagnostics by Product Type - Instruments and Consumables & Accessories - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 246: Rest of Latin America Historic Review for Colorectal Cancer Diagnostics by Product Type - Instruments and Consumables & Accessories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 247: Rest of Latin America 15-Year Perspective for Colorectal Cancer Diagnostics by Product Type - Percentage Breakdown of Value Sales for Instruments and Consumables & Accessories for the Years 2015, 2025 & 2030
• MIDDLE EAST
  • Colorectal Cancer Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
  • TABLE 248: Middle East Recent Past, Current & Future Analysis for Colorectal Cancer Diagnostics by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 249: Middle East Historic Review for Colorectal Cancer Diagnostics by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 250: Middle East 15-Year Perspective for Colorectal Cancer Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2015, 2025 & 2030
  • TABLE 251: Middle East Recent Past, Current & Future Analysis for Colorectal Cancer Diagnostics by Cancer Type - Adenocarcinoma, Colorectal Lymphoma, Gastrointestinal Stromal Tumors, Carcinoid Tumors and Other Cancer Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 252: Middle East Historic Review for Colorectal Cancer Diagnostics by Cancer Type - Adenocarcinoma, Colorectal Lymphoma, Gastrointestinal Stromal Tumors, Carcinoid Tumors and Other Cancer Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 253: Middle East 15-Year Perspective for Colorectal Cancer Diagnostics by Cancer Type - Percentage Breakdown of Value Sales for Adenocarcinoma, Colorectal Lymphoma, Gastrointestinal Stromal Tumors, Carcinoid Tumors and Other Cancer Types for the Years 2015, 2025 & 2030
  • TABLE 254: Middle East Recent Past, Current & Future Analysis for Colorectal Cancer Diagnostics by End-Use - Cancer Research Centers, Ambulatory Surgery Centers, Other End-Uses, Hospitals and Diagnostic Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 255: Middle East Historic Review for Colorectal Cancer Diagnostics by End-Use - Cancer Research Centers, Ambulatory Surgery Centers, Other End-Uses, Hospitals and Diagnostic Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 256: Middle East 15-Year Perspective for Colorectal Cancer Diagnostics by End-Use - Percentage Breakdown of Value Sales for Cancer Research Centers, Ambulatory Surgery Centers, Other End-Uses, Hospitals and Diagnostic Centers for the Years 2015, 2025 & 2030
  • TABLE 257: Middle East Recent Past, Current & Future Analysis for Colorectal Cancer Diagnostics by Product Type - Instruments and Consumables & Accessories - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 258: Middle East Historic Review for Colorectal Cancer Diagnostics by Product Type - Instruments and Consumables & Accessories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 259: Middle East 15-Year Perspective for Colorectal Cancer Diagnostics by Product Type - Percentage Breakdown of Value Sales for Instruments and Consumables & Accessories for the Years 2015, 2025 & 2030
• IRAN
  • TABLE 260: Iran Recent Past, Current & Future Analysis for Colorectal Cancer Diagnostics by Cancer Type - Adenocarcinoma, Colorectal Lymphoma, Gastrointestinal Stromal Tumors, Carcinoid Tumors and Other Cancer Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 261: Iran Historic Review for Colorectal Cancer Diagnostics by Cancer Type - Adenocarcinoma, Colorectal Lymphoma, Gastrointestinal Stromal Tumors, Carcinoid Tumors and Other Cancer Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 262: Iran 15-Year Perspective for Colorectal Cancer Diagnostics by Cancer Type - Percentage Breakdown of Value Sales for Adenocarcinoma, Colorectal Lymphoma, Gastrointestinal Stromal Tumors, Carcinoid Tumors and Other Cancer Types for the Years 2015, 2025 & 2030
  • TABLE 263: Iran Recent Past, Current & Future Analysis for Colorectal Cancer Diagnostics by End-Use - Cancer Research Centers, Ambulatory Surgery Centers, Other End-Uses, Hospitals and Diagnostic Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 264: Iran Historic Review for Colorectal Cancer Diagnostics by End-Use - Cancer Research Centers, Ambulatory Surgery Centers, Other End-Uses, Hospitals and Diagnostic Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 265: Iran 15-Year Perspective for Colorectal Cancer Diagnostics by End-Use - Percentage Breakdown of Value Sales for Cancer Research Centers, Ambulatory Surgery Centers, Other End-Uses, Hospitals and Diagnostic Centers for the Years 2015, 2025 & 2030
  • TABLE 266: Iran Recent Past, Current & Future Analysis for Colorectal Cancer Diagnostics by Product Type - Instruments and Consumables & Accessories - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 267: Iran Historic Review for Colorectal Cancer Diagnostics by Product Type - Instruments and Consumables & Accessories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 268: Iran 15-Year Perspective for Colorectal Cancer Diagnostics by Product Type - Percentage Breakdown of Value Sales for Instruments and Consumables & Accessories for the Years 2015, 2025 & 2030
• ISRAEL
  • TABLE 269: Israel Recent Past, Current & Future Analysis for Colorectal Cancer Diagnostics by Cancer Type - Adenocarcinoma, Colorectal Lymphoma, Gastrointestinal Stromal Tumors, Carcinoid Tumors and Other Cancer Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 270: Israel Historic Review for Colorectal Cancer Diagnostics by Cancer Type - Adenocarcinoma, Colorectal Lymphoma, Gastrointestinal Stromal Tumors, Carcinoid Tumors and Other Cancer Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 271: Israel 15-Year Perspective for Colorectal Cancer Diagnostics by Cancer Type - Percentage Breakdown of Value Sales for Adenocarcinoma, Colorectal Lymphoma, Gastrointestinal Stromal Tumors, Carcinoid Tumors and Other Cancer Types for the Years 2015, 2025 & 2030
  • TABLE 272: Israel Recent Past, Current & Future Analysis for Colorectal Cancer Diagnostics by End-Use - Cancer Research Centers, Ambulatory Surgery Centers, Other End-Uses, Hospitals and Diagnostic Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 273: Israel Historic Review for Colorectal Cancer Diagnostics by End-Use - Cancer Research Centers, Ambulatory Surgery Centers, Other End-Uses, Hospitals and Diagnostic Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 274: Israel 15-Year Perspective for Colorectal Cancer Diagnostics by End-Use - Percentage Breakdown of Value Sales for Cancer Research Centers, Ambulatory Surgery Centers, Other End-Uses, Hospitals and Diagnostic Centers for the Years 2015, 2025 & 2030
  • TABLE 275: Israel Recent Past, Current & Future Analysis for Colorectal Cancer Diagnostics by Product Type - Instruments and Consumables & Accessories - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 276: Israel Historic Review for Colorectal Cancer Diagnostics by Product Type - Instruments and Consumables & Accessories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 277: Israel 15-Year Perspective for Colorectal Cancer Diagnostics by Product Type - Percentage Breakdown of Value Sales for Instruments and Consumables & Accessories for the Years 2015, 2025 & 2030
• SAUDI ARABIA
  • TABLE 278: Saudi Arabia Recent Past, Current & Future Analysis for Colorectal Cancer Diagnostics by Cancer Type - Adenocarcinoma, Colorectal Lymphoma, Gastrointestinal Stromal Tumors, Carcinoid Tumors and Other Cancer Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 279: Saudi Arabia Historic Review for Colorectal Cancer Diagnostics by Cancer Type - Adenocarcinoma, Colorectal Lymphoma, Gastrointestinal Stromal Tumors, Carcinoid Tumors and Other Cancer Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 280: Saudi Arabia 15-Year Perspective for Colorectal Cancer Diagnostics by Cancer Type - Percentage Breakdown of Value Sales for Adenocarcinoma, Colorectal Lymphoma, Gastrointestinal Stromal Tumors, Carcinoid Tumors and Other Cancer Types for the Years 2015, 2025 & 2030
  • TABLE 281: Saudi Arabia Recent Past, Current & Future Analysis for Colorectal Cancer Diagnostics by End-Use - Cancer Research Centers, Ambulatory Surgery Centers, Other End-Uses, Hospitals and Diagnostic Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 282: Saudi Arabia Historic Review for Colorectal Cancer Diagnostics by End-Use - Cancer Research Centers, Ambulatory Surgery Centers, Other End-Uses, Hospitals and Diagnostic Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 283: Saudi Arabia 15-Year Perspective for Colorectal Cancer Diagnostics by End-Use - Percentage Breakdown of Value Sales for Cancer Research Centers, Ambulatory Surgery Centers, Other End-Uses, Hospitals and Diagnostic Centers for the Years 2015, 2025 & 2030
  • TABLE 284: Saudi Arabia Recent Past, Current & Future Analysis for Colorectal Cancer Diagnostics by Product Type - Instruments and Consumables & Accessories - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 285: Saudi Arabia Historic Review for Colorectal Cancer Diagnostics by Product Type - Instruments and Consumables & Accessories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 286: Saudi Arabia 15-Year Perspective for Colorectal Cancer Diagnostics by Product Type - Percentage Breakdown of Value Sales for Instruments and Consumables & Accessories for the Years 2015, 2025 & 2030
• UNITED ARAB EMIRATES
  • TABLE 287: UAE Recent Past, Current & Future Analysis for Colorectal Cancer Diagnostics by Cancer Type - Adenocarcinoma, Colorectal Lymphoma, Gastrointestinal Stromal Tumors, Carcinoid Tumors and Other Cancer Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 288: UAE Historic Review for Colorectal Cancer Diagnostics by Cancer Type - Adenocarcinoma, Colorectal Lymphoma, Gastrointestinal Stromal Tumors, Carcinoid Tumors and Other Cancer Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 289: UAE 15-Year Perspective for Colorectal Cancer Diagnostics by Cancer Type - Percentage Breakdown of Value Sales for Adenocarcinoma, Colorectal Lymphoma, Gastrointestinal Stromal Tumors, Carcinoid Tumors and Other Cancer Types for the Years 2015, 2025 & 2030
  • TABLE 290: UAE Recent Past, Current & Future Analysis for Colorectal Cancer Diagnostics by End-Use - Cancer Research Centers, Ambulatory Surgery Centers, Other End-Uses, Hospitals and Diagnostic Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 291: UAE Historic Review for Colorectal Cancer Diagnostics by End-Use - Cancer Research Centers, Ambulatory Surgery Centers, Other End-Uses, Hospitals and Diagnostic Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 292: UAE 15-Year Perspective for Colorectal Cancer Diagnostics by End-Use - Percentage Breakdown of Value Sales for Cancer Research Centers, Ambulatory Surgery Centers, Other End-Uses, Hospitals and Diagnostic Centers for the Years 2015, 2025 & 2030
  • TABLE 293: UAE Recent Past, Current & Future Analysis for Colorectal Cancer Diagnostics by Product Type - Instruments and Consumables & Accessories - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 294: UAE Historic Review for Colorectal Cancer Diagnostics by Product Type - Instruments and Consumables & Accessories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 295: UAE 15-Year Perspective for Colorectal Cancer Diagnostics by Product Type - Percentage Breakdown of Value Sales for Instruments and Consumables & Accessories for the Years 2015, 2025 & 2030
• REST OF MIDDLE EAST
  • TABLE 296: Rest of Middle East Recent Past, Current & Future Analysis for Colorectal Cancer Diagnostics by Cancer Type - Adenocarcinoma, Colorectal Lymphoma, Gastrointestinal Stromal Tumors, Carcinoid Tumors and Other Cancer Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 297: Rest of Middle East Historic Review for Colorectal Cancer Diagnostics by Cancer Type - Adenocarcinoma, Colorectal Lymphoma, Gastrointestinal Stromal Tumors, Carcinoid Tumors and Other Cancer Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 298: Rest of Middle East 15-Year Perspective for Colorectal Cancer Diagnostics by Cancer Type - Percentage Breakdown of Value Sales for Adenocarcinoma, Colorectal Lymphoma, Gastrointestinal Stromal Tumors, Carcinoid Tumors and Other Cancer Types for the Years 2015, 2025 & 2030
  • TABLE 299: Rest of Middle East Recent Past, Current & Future Analysis for Colorectal Cancer Diagnostics by End-Use - Cancer Research Centers, Ambulatory Surgery Centers, Other End-Uses, Hospitals and Diagnostic Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 300: Rest of Middle East Historic Review for Colorectal Cancer Diagnostics by End-Use - Cancer Research Centers, Ambulatory Surgery Centers, Other End-Uses, Hospitals and Diagnostic Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 301: Rest of Middle East 15-Year Perspective for Colorectal Cancer Diagnostics by End-Use - Percentage Breakdown of Value Sales for Cancer Research Centers, Ambulatory Surgery Centers, Other End-Uses, Hospitals and Diagnostic Centers for the Years 2015, 2025 & 2030
  • TABLE 302: Rest of Middle East Recent Past, Current & Future Analysis for Colorectal Cancer Diagnostics by Product Type - Instruments and Consumables & Accessories - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 303: Rest of Middle East Historic Review for Colorectal Cancer Diagnostics by Product Type - Instruments and Consumables & Accessories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 304: Rest of Middle East 15-Year Perspective for Colorectal Cancer Diagnostics by Product Type - Percentage Breakdown of Value Sales for Instruments and Consumables & Accessories for the Years 2015, 2025 & 2030
• AFRICA
  • Colorectal Cancer Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
  • TABLE 305: Africa Recent Past, Current & Future Analysis for Colorectal Cancer Diagnostics by Cancer Type - Adenocarcinoma, Colorectal Lymphoma, Gastrointestinal Stromal Tumors, Carcinoid Tumors and Other Cancer Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 306: Africa Historic Review for Colorectal Cancer Diagnostics by Cancer Type - Adenocarcinoma, Colorectal Lymphoma, Gastrointestinal Stromal Tumors, Carcinoid Tumors and Other Cancer Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 307: Africa 15-Year Perspective for Colorectal Cancer Diagnostics by Cancer Type - Percentage Breakdown of Value Sales for Adenocarcinoma, Colorectal Lymphoma, Gastrointestinal Stromal Tumors, Carcinoid Tumors and Other Cancer Types for the Years 2015, 2025 & 2030
  • TABLE 308: Africa Recent Past, Current & Future Analysis for Colorectal Cancer Diagnostics by End-Use - Cancer Research Centers, Ambulatory Surgery Centers, Other End-Uses, Hospitals and Diagnostic Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 309: Africa Historic Review for Colorectal Cancer Diagnostics by End-Use - Cancer Research Centers, Ambulatory Surgery Centers, Other End-Uses, Hospitals and Diagnostic Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 310: Africa 15-Year Perspective for Colorectal Cancer Diagnostics by End-Use - Percentage Breakdown of Value Sales for Cancer Research Centers, Ambulatory Surgery Centers, Other End-Uses, Hospitals and Diagnostic Centers for the Years 2015, 2025 & 2030
  • TABLE 311: Africa Recent Past, Current & Future Analysis for Colorectal Cancer Diagnostics by Product Type - Instruments and Consumables & Accessories - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 312: Africa Historic Review for Colorectal Cancer Diagnostics by Product Type - Instruments and Consumables & Accessories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 313: Africa 15-Year Perspective for Colorectal Cancer Diagnostics by Product Type - Percentage Breakdown of Value Sales for Instruments and Consumables & Accessories for the Years 2015, 2025 & 2030

IV. COMPETITION